In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD
WHO Europe - EURO
Christopher Gilpin, PhD, MPH
World Health Organization - WHO
Dylan Tierney
Brigham and Women's Hospital, Division of Global Health Equity

Current Expert Panels

Anti-TB Drugs and Arrhythmia: Theoretical Concern or Real Risk?

July 6, 2015 - July 10, 2015 13 Replies

This Expert Panel explores the risk of QT prolongation in emerging drug-resistant tuberculosis (DR-TB) therapy.

Patient Preferences for New TB Diagnostic Tests

May 25, 2015 - May 29, 2015 64 Replies

The World Health Organization is developing guidance on the use of LAM and TB-LAMP. Join experts in discussing these new diagnostics for TB and share your input with the community.

Recent discussion topics

Expert Panel on TB Transmission Risk Reduction (July 13 – 17)

By Sudip Bhandari on 06 Jul, 2015 0 Replies

We’re excited to announce that we’ll be hosting an Expert Panel on new rapid molecular techniques and TB transmission risk reduction on our TB-IC community July 13 – 17. We have great panelists who will discuss field implementation issues of new diagnostic…

what are the Min lab tests for start bedaquiline???

By Anita qaffari.MD on 04 Jul, 2015 0 Replies

Annex 2. Minimum laboratory requirements for introduction of bedaquiline Laboratory requirements Smear (ZN and/or FM) Rapid molecular tests (Xpert® and/or LPA) Culture (solid and/or liquid) Diagnosis of MDR-TB (at least RR-TB) EQA system in place Access to…


By Anita qaffari.MD on 04 Jul, 2015 0 Replies


New community members

User Photo

Marie Teichman

Affiliated Organizations


Work Locations

United States

User Photo

Lauren Cirrincione

Affiliated Organizations

Fulbright U.S. Student Program

Work Locations

South Africa

beatrixb's Profile Image

Beatrix Balogh

I focus more in the quantitative research for a healthcare team at an applied think tank that focuses on emerging markets. My main work has been in mathematical modeling of disease transmission (for TB and malaria), but I also work on system dynamics for health technologies/products such as the DMPA contraceptive.

Affiliated Organizations

University of Michigan; William Davidson Institute

Work Locations

United States